Acute hepatic injury following treatment of a long-acting insulin analogue overdose necessitating urgent insulin depot excision

Diabetic Medicine

Volumn 29, Issue 2, 2012, Pages 232-235

  Warriner, D ^a   Debono, M ^a   Gandhi, R A ^a   Chong, E ^a   Creagh, F ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glucose metabolism; Glycaemic control; Insulin; Pharmacokinetics; Therapeutics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LACTIC ACID; LEVOTHYROXINE; NEUTRAL INSULIN; SIMVASTATIN; THYROTROPIN;

ABDOMINAL WALL; ACUTE DISEASE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BORDERLINE STATE; CASE REPORT; DISEASE ASSOCIATION; DRUG OVERDOSE; ECHOGRAPHY; EPIGASTRIC PAIN; EXCISION; FAT NECROSIS; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; IMPULSIVENESS; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INJECTION SITE NECROSIS; INSULIN DEPENDENT DIABETES MELLITUS; LACTATE BLOOD LEVEL; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MALE; PATIENT COMPLIANCE; SUPPLEMENTATION; THYROTROPIN BLOOD LEVEL;

ABDOMEN; ADULT; DEVICE REMOVAL; DIABETES MELLITUS, TYPE 1; GLUCOSE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN, LONG-ACTING; LIVER; MALE; OVERDOSE; TREATMENT OUTCOME;

EID: 84855818060     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03385.x     Document Type: Article

References (11)

1. Tsujimoto T, Takano M, Nishiofuku M, Yoshiji H, Matsumura Y, Kuriyama S et al. Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose. Intern Med 2006; 45: 469-473.
2. von Mach MA, Meyer S, Omogbehin B, Kann PH, Weilemann LS. Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit. Int J Clin Pharmacol Ther 2004; 42: 277-280.
3. Roberge RJ, Martin TG, Delbridge TR. Intentional massive insulin overdose: recognition and management. Ann Emerg Med 1993; 22: 228-234.
4. Jolliet P, Leverve X, Pichard C. Acute hepatic steatosis complicating massive insulin overdose and excessive glucose administration. Intensive Care Med 2001; 27: 313-316.
5. Fuller ET, Miller MA, Kaylor DW, Janke C. Lantus overdose: case presentation and management options. J Emerg Med 2009; 36: 26-29.
6. Cuthbertson DJ, Brennan G, Walsh S, Henry E. Hepatic glycogenosis: abnormal liver function tests in Type 1 diabetes. Diabet Med 2007; 24: 322-323.
7. Abaci A, Bekem O, Unuvar T, Ozer E, Bober E, Arslan N et al. Hepatic glycogenosis: a rare cause of hepatomegaly in Type 1 diabetes mellitus. J Diabetes Complications 2008; 22: 325-328.
8. Bua J, Marchetti F, Faleschini E, Ventura A, Bussani R. Hepatic glycogenosis in an adolescent with diabetes. J Pediatr; 157: 1042.
9. Campbell IW, Ratcliffe JG. Suicidal insulin overdose managed by excision of insulin injection site. Br Med J (Clin Res Ed) 1982; 285: 408-409.
10. Thewjitcharoen Y, Lekpittaya N, Himathongkam T. Attempted suicide by massive insulin injection: a case report and review of the literature. J Med Assoc Thai 2008; 91: 1920-1924.
11. Megarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay JM et al. Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care 2007; 11: R115.